Figure 2. Individual-Level Measurements for the Primary and Secondary Outcomes.

The primary outcome is magnetic resonance imaging (MRI) proton density fat fraction measurement of hepatic steatosis (panel A) and levels of alanine aminotransferase, aspartate aminotransferase, and γ-glutamyl transpeptidase (panels B-D) are secondary outcomes. Each vertical line represents 1 child sorted by treatment and baseline value. The baseline values are on the dotted line and the 8-week values are represented by the circles.